Can more lutathera stop tumor progression? new study seeks answers
NCT ID NCT04954820
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study is for people with intestinal neuroendocrine tumors that have started growing again after initial treatment with Lutathera. It compares giving two more cycles of Lutathera versus simply monitoring the tumor over six months. The goal is to see if extra treatment can better control the disease. About 146 adults will take part.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INTESTINAL WELL DIFFERENTIATED ENDOCRINE TUMOR are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
CH Métropole de Savoie
RECRUITINGChambéry, 73011, France
-
CHRU Lille
RECRUITINGLille, 59000, France
-
CHRU Morvan
RECRUITINGBrest, 29200, France
-
CHRU Nancy Brabois
RECRUITINGVandœuvre-lès-Nancy, 54511, France
-
CHU Grenoble Alpes (CHUGA)
RECRUITINGLa Tronche, 38700, France
-
CHU Nantes
RECRUITINGNantes, 44093, France
-
CHU ST Etienne
RECRUITINGSaint-Etienne, 42055, France
-
CHU de DIJON
RECRUITINGDijon, 21079, France
-
CHU de Rouen
NOT_YET_RECRUITINGRouen, 76031, France
-
Centre Antoine Lacassagne
RECRUITINGNice, 06189, France
-
Centre François Baclesse
RECRUITINGCaen, 14076, France
-
Centre Henri Becquerel
RECRUITINGRouen, 76000, France
-
Centre Jean Perrin
RECRUITINGClermont-Ferrand, 63011, France
-
Centre léon bérard
RECRUITINGLyon, 69008, France
-
Hopital Beaujon
RECRUITINGClichy, 92110, France
-
Hospices civils de LYON - GHE
RECRUITINGBron, 69677, France
-
Hôpital Cochin
RECRUITINGParis, 75014, France
-
Hôpital Haut-Lévêque
RECRUITINGPessac, 33604, France
-
Hôpital Pitié Salpétrière
RECRUITINGParis, 75013, France
-
Hôpital de la Timone
RECRUITINGMarseille, 13385, France
-
Hôpitaux Universitaires de Strasbourg
RECRUITINGStrasbourg, 67091, France
-
ICM Val d'Aurelle
RECRUITINGMontpellier, 34298, France
-
IUCT Oncopole
RECRUITINGToulouse, 31100, France
-
Institut Bergonié
RECRUITINGBordeaux, 33000, France
-
Institut Gustave Roussy
RECRUITINGVillejuif, 94805, France
-
Institut Paoli Calmettes
RECRUITINGMarseille, 13009, France
-
Institut de Cancérologie de l'Ouest
RECRUITINGSaint-Herblain, 44805, France
-
Institut de Cancérologie de l'Ouest Site d'Angers
RECRUITINGAngers, 49055, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- One dose may not fit all: blood tests could tailor cancer drug dosing
- Can a new 'Nanobody' tracer outsmart standard scans for neuroendocrine cancers?
- Can a Three-Drug cocktail shrink Hard-to-Treat neuroendocrine tumors?
- Experimental drug targets Hard-to-Treat neuroendocrine cancers
- New camera could make cancer treatment safer by better tracking radiation
- Radioactive drug targets hard-to-treat neuroendocrine tumors in early trial